46th Annual William Blair Growth Stock Conference
Logotype for Novanta Inc

Novanta (NOVT) 46th Annual William Blair Growth Stock Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Novanta Inc

46th Annual William Blair Growth Stock Conference summary

6 Jun, 2026

Strategic direction and market focus

  • Shifted portfolio from 10% to 53% medical end markets, reducing cyclicality and increasing exposure to robotics and automation.

  • Reduced semiconductor exposure from 40-50% to 10-15%, while healthcare exposure rose to 50-55%.

  • 98% of business is sole source proprietary IP, with long-term design-in cycles and sticky revenue streams.

  • Addressable market estimated at $7 billion, with focus on high-growth, secular trends in minimally invasive and robotic surgery, precision medicine, and industrial automation.

  • Asset-light model with 100% free cash flow conversion, reinvested in organic growth and M&A.

Innovation and product platforms

  • Leading in end-of-arm technologies for surgical robotics, including sensing and motion control for precise movement and haptic feedback.

  • Medical consumables now 15% of portfolio, up from 0% eight years ago, growing at double digits and tied to procedural growth rates.

  • Intelligent subsystems, combining components and embedded software, now 30% of business, up from less than 5% a decade ago.

  • 15% of sales linked to GenAI infrastructure, including EUV lithography and GPU drilling, growing 20% last quarter.

  • Insufflation and fluid management platform is a category leader, with plans to double business by 2030.

Growth engines and operational model

  • M&A flywheel with over 20 acquisitions in the last decade, compounding mid to high single-digit organic growth to double digits.

  • Focus on recurring revenue streams, especially in medical consumables and intelligent subsystems.

  • Proprietary safety technology for robotics, enabling safe human-robot interaction, with significant volume expected by 2028-2030.

  • Precision motion and light manipulation technologies drive applications in 3D printing, semiconductor testing, and life sciences.

  • Decentralized entrepreneurial business units balanced with coordinated key account management and operational excellence systems.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more